Tragante, V., Asselbergs, F. W., Swerdlow, D. I., Palmer, T. M., Moore, J. H., de Bakker, P. I. W., . . . Holmes, M. V. (2016). Harnessing publicly available genetic data to prioritize lipid modifying therapeutic targets for prevention of coronary heart disease based on dysglycemic risk. Hum Genet.
Citación estilo ChicagoTragante, Vinicius, Folkert W. Asselbergs, Daniel I. Swerdlow, Tom M. Palmer, Jason H. Moore, Paul I. W. de Bakker, Brendan J. Keating, and Michael V. Holmes. "Harnessing Publicly Available Genetic Data to Prioritize Lipid Modifying Therapeutic Targets for Prevention of Coronary Heart Disease Based On Dysglycemic Risk." Hum Genet 2016.
Cita MLATragante, Vinicius, et al. "Harnessing Publicly Available Genetic Data to Prioritize Lipid Modifying Therapeutic Targets for Prevention of Coronary Heart Disease Based On Dysglycemic Risk." Hum Genet 2016.